Low somatostatin content in cerebrospinal fluid in multiple sclerosis
- 1 March 1980
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 61 (3), 186-191
- https://doi.org/10.1111/j.1600-0404.1980.tb01481.x
Abstract
In 27 patients with multiple sclerosis (MS), and in 10 control subjects of comparable age, percent ideal body weight and sex ratio, the cerebrospinal fluid (CSF) content of somatostatin was measured by radioimmunoassay. The results showed that the group of patients in relapse (n = 16) had significantly lower somatostatin content in CSF (95 ± 4.1 (SEM) pg/ml) than both the control group (142 ± 8.4 pg/ml) and the group of MS patients (n =11), who had been in a clinical stable phase for more than 6 months (131 ± 3.2 pg/ml). Duration of the disease and degree of neurological impairment were apparently without relation to the reduction of somatostatin content in the CSF. There was no relationship between CSF content of somatostatin and the content of total protein or IgG, neither of which showed any relationship to the activity of the disease.Keywords
This publication has 14 references indexed in Scilit:
- Characterisation of somatostatin release from the pancreasDiabetologia, 1979
- SomatostatinPublished by Elsevier ,1978
- Somatostatin in Human Cerebrospinal FluidNew England Journal of Medicine, 1977
- Immunohistochemical evidence for the presence of somatostatin, a powerful inhibitory peptide, in some primary sensory neuronsNeuroscience Letters, 1975
- Somatostatin: Abundance of Immunoreactive Hormone in Rat Stomach and PancreasScience, 1975
- Evidence for the D-Cell of the Pancreas Secreting SomatostatinHormone and Metabolic Research, 1975
- Measurement of and Correction for Incubation Damage in RadioimmunoassayEuropean Journal of Clinical Investigation, 1974
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973
- Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth HormoneNature, 1968
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965